Inhibition of tumor necrosis factor alpha reduces the outgrowth of hepatic micrometastasis of colorectal tumors in a mouse model of liver ischemia-reperfusion injury

Journal of Biomedical Science

Volumn 21, Issue 1, 2014, Pages

  Jiao, Shu Fan ^a   Sun, Kai ^a   Chen, Xiao Jing ^a   Zhao, Xue ^a   Cai, Ning ^a   Liu, Yan Jun ^c   Xu, Long Mei ^a   Kong, Xian Ming ^a   Wei, Li Xin ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c Shanghai Pharmaceutical Holding Co Ltd   (China)

Author keywords

Colorectal cancer; Enbrel; Ischemia reperfusion; Liver metastases; TNF

Indexed keywords

IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; COLORECTAL TUMOR; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; HUMAN; INJURY; LIVER; LIVER TUMOR; METASTASIS; MICROMETASTASIS; MOUSE; PATHOLOGY; REPERFUSION INJURY;

ANIMALS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN G; LIVER; LIVER NEOPLASMS; MICE; NEOPLASM MICROMETASTASIS; RECEPTORS, TUMOR NECROSIS FACTOR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892143444     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-21-1     Document Type: Article

References (51)

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM, Int J Cancer 2010 127 2893 2917 10.1002/ijc.25516 21351269
2. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O, Eur J Cancer 2003 39 718 727 10.1016/S0959-8049(02)00811-0 12651195 (Pubitemid 36315986)
3. Global cancer statistics. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, CA Cancer J Clin 2011 61 69 90 10.3322/caac.20107 21296855
4. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: a 10-year single-institute experience. Mutsaerts EL, van Ruth S, Zoetmulder FA, Rutgers EJ, Hart AA, van Coevorden F, J Gastrointest Surg 2005 9 178 186 10.1016/j.gassur.2004.06.005 15694813 (Pubitemid 40202975)
5. Extending limits of resection for metastatic colorectal cancer: risk benefit ratio. Yang AD, Brouquet A, Vauthey JN, J Surg Oncol 2010 102 996 1001 10.1002/jso.21701 21166004
6. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, Voest EE, van Diest PJ, Borel Rinkes IH, Hepatology 2005 42 165 175 10.1002/hep.20739 15962318 (Pubitemid 40911324)
7. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. Doi K, Horiuchi T, Uchinami M, Tabo T, Kimura N, Yokomachi J, Yoshida M, Tanaka K, J Surg Res 2002 105 243 247 10.1006/jsre.2002.6356 12121713 (Pubitemid 34765333)
8. Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Nicoud IB, Jones CM, Pierce JM, Earl TM, Matrisian LM, Chari RS, Gorden DL, Cancer Res 2007 67 2720 2728 10.1158/0008-5472.CAN-06-3923 17363593 (Pubitemid 46548960)
9. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr, J Clin Invest 1990 85 1936 1943 10.1172/JCI114656 2161433 (Pubitemid 20192970)
10. Inhibition of TNF-alpha protects against hepatic ischemia-reperfusion injury in rats via NF-kappaB dependent pathway. Mahmoud MF, El Shazly SM, Barakat W, Naunyn Schmiedebergs Arch Pharmacol 2012 385 465 471 10.1007/s00210-012-0729-z 22311349
11. Ischaemic postconditioning reduces peroxide formation, cytokine expression and leukocyte activation in reperfusion injury after abdominal aortic surgery in rat model. Sinay L, Kurthy M, Horvath S, Arato E, Shafiei M, Lantos J, Ferencz S, Bator A, Balatonyi B, Verzar Z, et al. Clin Hemorheol Microcirc 2008 40 133 142 19029638
12. Inhibition of myocardial apoptosis by postconditioning is associated with attenuation of oxidative stress-mediated nuclear factor-kappa B translocation and TNF alpha release. Kin H, Wang NP, Mykytenko J, Reeves J, Deneve J, Jiang R, Zatta AJ, Guyton RA, Vinten-Johansen J, Zhao ZQ, Shock 2008 29 761 768 18496137 (Pubitemid 351769941)
13. Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Culy CR, Keating GM, Drugs 2002 62 2493 2537 12421111 (Pubitemid 35448141)
14. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP, Pharmacol Ther 2008 117 244 279 10.1016/j.pharmthera.2007.10.001 18155297
15. Etanercept: efficacy and safety for approved indications. Kerensky TA, Gottlieb AB, Yaniv S, Au SC, Expert Opin Drug Saf 2012 11 121 139 10.1517/14740338.2012.633509 22074366
16. Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation. Yanik GA, Mineishi S, Levine JE, Kitko CL, White ES, Vander Lugt MT, Harris AC, Braun T, Cooke KR, Biol Blood Marrow Transplant 2012 18 1044 1054 10.1016/j.bbmt.2011.11. 031 22155140
17. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Teoh N, Leclercq I, Pena AD, Farrell G, Hepatology 2003 37 118 128 10.1053/jhep.2003.50009 12500196 (Pubitemid 36042152)
18. Administration of low doses of tumor necrosis factor-alpha protects rat liver from ischaemic damage and reperfusion injury. Helewski KJ, Kowalczyk-Ziomek GI, Czecior E, Swietochowska E, Wielkoszynski T, Czuba ZP, Szliszka E, Krol W, J Physiol Pharmacol 2010 61 273 278 20610856
19. Tumour necrosis factor and cancer. Balkwill F, Nat Rev Cancer 2009 9 361 371 10.1038/nrc2628 19343034
20. Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Rudiger HA, Clavien PA, Gastroenterology 2002 122 202 210 10.1053/gast.2002.30304 11781294 (Pubitemid 34049208)
21. Dual role of tumor necrosis factor-alpha in hepatic ischemia-reperfusion injury: studies in tumor necrosis factor-alpha gene knockout mice. Teoh N, Field J, Sutton J, Farrell G, Hepatology 2004 39 412 421 10.1002/hep.20035 14767994 (Pubitemid 38222182)
22. Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats. Yang YL, Li JP, Xu XP, Dou KF, Yue SQ, Li KZ, World J Gastroenterol 2004 10 3161 3164 15457564
23. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Jaeschke H, Am J Physiol Gastrointest Liver Physiol 2003 284 15 G26 12488232
24. Hepatic ischemia reperfusion injury: Contemporary perspectives on pathogenic mechanisms and basis for hepatoprotection-the good, bad and deadly. Teoh NC, J Gastroenterol Hepatol 2011 26 Suppl 1 180 187 21199530
25. Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion. Okaya T, Lentsch AB, J Invest Surg 2003 16 141 147 12775430 (Pubitemid 36926518)
26. Neutrophil depletion and chemokine response after liver ischemia and reperfusion. Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, Ward PA, J Invest Surg 2001 14 99 107 10.1080/08941930152024228 11396626 (Pubitemid 32529851)
27. [Neutrophils' contribution to ischaemia and reperfusion injury in liver]. Helewski KJ, Kowalczyk-Ziomek GI, Konecki J, Wiad Lek 2007 60 47 52 17607968
28. Inflammation: a driving force speeds cancer metastasis. Wu Y, Zhou BP, Cell Cycle 2009 8 3267 3273 10.4161/cc.8.20.9699 19770594
29. The tumor microenvironment: a critical determinant of neoplastic evolution. van Kempen LC, Ruiter DJ, van Muijen GN, Coussens LM, Eur J Cell Biol 2003 82 539 548 10.1078/0171-9335-00346 14703010 (Pubitemid 38008835)
30. Inhibition of matrix metalloproteinase-9 attenuates acute small-for-size liver graft injury in rats. Ma ZY, Qian JM, Rui XH, Wang FR, Wang QW, Cui YY, Peng ZH, Am J Transplant: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010 10 784 795 10.1111/j.1600-6143.2009.02993.x
31. Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. Khandoga A, Kessler JS, Hanschen M, Khandoga AG, Burggraf D, Reichel C, Hamann GF, Enders G, Krombach F, J Leukoc Biol 2006 79 1295 1305 10.1189/jlb.0805468 16551680 (Pubitemid 44835565)
32. Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer. Yoshimoto K, Tajima H, Ohta T, Okamoto K, Sakai S, Kinoshita J, Furukawa H, Makino I, Hayashi H, Nakamura K, et al. Oncol Rep 2012 28 791 796 22766603
33. Protection from ischemia-reperfusion induced severe acute renal failure by blocking E-selectin. Singbartl K, Ley K, Crit Care Med 2000 28 2507 2514 10921586 (Pubitemid 30604461)
34. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H, Cancer Lett 2000 151 31 38 10.1016/S0304-3835(99)00401-2 10766420 (Pubitemid 30155582)
35. Serum interleukin-6 levels in colorectal cancer patients-a summary of published results. Knupfer H, Preiss R, Int J Colorectal Dis 2010 25 135 140 10.1007/s00384-009-0818-8 19898853
36. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Condeelis J, Pollard JW, Cell 2006 124 263 266 10.1016/j.cell.2006. 01.007 16439202 (Pubitemid 43121975)
37. The role of myeloid cells in the promotion of tumour angiogenesis. Murdoch C, Muthana M, Coffelt SB, Lewis CE, Nat Rev Cancer 2008 8 618 631 10.1038/nrc2444 18633355
38. Corrupt policemen: inflammatory cells promote tumor angiogenesis. Zumsteg A, Christofori G, Curr Opin Oncol 2009 21 60 70 10.1097/CCO.0b013e32831bed7e 19125020
39. Concepts of epigenetics in prostate cancer development. Cooper CS, Foster CS, Br J Cancer 2009 100 240 245 10.1038/sj.bjc.6604771 19002169
40. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Hahn MA, Hahn T, Lee DH, Esworthy RS, Kim BW, Riggs AD, Chu FF, Pfeifer GP, Cancer Res 2008 68 10280 10289 10.1158/0008-5472.CAN-08-1957 19074896
41. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Edwards RA, Witherspoon M, Wang K, Afrasiabi K, Pham T, Birnbaumer L, Lipkin SM, Cancer Res 2009 69 6423 6429 10.1158/0008-5472.CAN-09-1285 19638594
42. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer. Jin B, Yao B, Li JL, Fields CR, Delmas AL, Liu C, Robertson KD, Cancer Res 2009 69 7412 7421 10.1158/0008-5472.CAN-09-0116 19723660
43. Inflammation-mediated genetic and epigenetic alterations drive cancer development in the neighboring epithelium upon stromal abrogation of TGF-beta signaling. Achyut BR, Bader DA, Robles AI, Wangsa D, Harris CC, Ried T, Yang L, PLoS Genet 2013 9 1003251 10.1371/journal.pgen.1003251 23408900
44. Indirect action of tumor necrosis factor-alpha in liver injury during the CD8+ T cell response to an adeno-associated virus vector in mice. Giannandrea M, Pierce RH, Crispe IN, Hepatology 2009 49 2010 2020 10.1002/hep.22869 19291774
45. Dual effects of heat stress on tumor necrosis factor-alpha-induced hepatocyte apoptosis in mice. Imao M, Nagaki M, Moriwaki H, Lab Invest 2006 86 959 967 10.1038/labinvest.3700451 16832353 (Pubitemid 44268170)
46. Malignant mesothelioma: facts, myths, and hypotheses. Carbone M, Ly BH, Dodson RF, Pagano I, Morris PT, Dogan UA, Gazdar AF, Pass HI, Yang H, J Cell Physiol 2012 227 44 58 10.1002/jcp.22724 21412769
47. Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Cordero JB, Macagno JP, Stefanatos RK, Strathdee KE, Cagan RL, Vidal M, Dev Cell 2010 18 999 1011 10.1016/j.devcel.2010.05.014 20627081
48. Role of Heme Oxygenase 1 in TNF/TNF receptor-mediated apoptosis after hepatic ischemia/reperfusion in rats. Kim SJ, Eum HA, Billiar TR, Lee SM, Shock 2013 39 380 388 10.1097/SHK.0b013e31828aab7f 23423194
49. Inflammation and oncogenesis: a vicious connection. Grivennikov SI, Karin M, Curr Opin Genet Dev 2010 20 65 71 10.1016/j.gde.2009.11.004 20036794
50. Advances in the regulation of liver regeneration. Jia C, Expert Rev Gastroenterol Hepatol 2011 5 105 121 10.1586/egh.10.87 21309676
51. Tumor necrosis factor. Chu WM, Cancer Lett 2013 328 222 225 10.1016/j.canlet.2012.10.014 23085193